Study Stopped
funding
Examination of Cognitive Function in Obesity and Following Weight Loss
Longitudinal Assessment of Cognitive Function Following Bariatric Surgery or Medical Weight Loss Treatment
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
Bariatric surgery is the most effective, long-term treatment for morbid obesity, and consistent with previous findings, individuals who lose significant weight after surgery also have improved cognition or "brain function". The mechanisms behind these cognitive improvements are currently unknown, but are the focus of much research effort. The goal of this pilot study is to thoroughly describe these changes in surgical versus medical weight loss patients over time in a repeated measures fashion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2018
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2016
CompletedFirst Posted
Study publicly available on registry
December 15, 2016
CompletedStudy Start
First participant enrolled
July 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2020
CompletedSeptember 27, 2018
September 1, 2018
1.4 years
December 12, 2016
September 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cognitive Function Score
Within group and between group longitudinal measurements will be made using longitudinal regression methods. Baseline as well as 1, 3 and 6 month measurements will be captured either from the time of bariatric surgery or initiation of a supervised medical weight loss program.
Repeated Measures Up to 6 Months
Cognitive Function Score - Surgical Group Comparison
Within group and between group longitudinal measurements will be made using longitudinal regression methods. Baseline as well as 1, 3 and 6 month measurements will be captured either from the time of bariatric surgery or initiation of a supervised medical weight loss program. The bariatric operation will be included (Roux-en-Y gastric bypass vs. Vertical Sleeve Gastrectomy) as a variable in the regression model for between and within subjects comparisons in the bariatric surgery group.
Repeated Measures Up to 6 Months
Secondary Outcomes (1)
Cognitive Function Score - Crossover Patients
Repeated Measures Up to 6 Months
Study Arms (2)
Surgical Weight Loss
Patients in this group are those that will be undergoing bariatric surgery (either Roux-en-Y gastric bypass or vertical sleeve gastrectomy).
Medical Weight Loss
Patients in this group are those who are being enrolled in a supervised medical weight loss program.
Interventions
These are patients who will be having either Vertical Sleeve Gastrectomy or Roux-en-Y Gastric Bypass.
These are patients who will be starting a structured medical weight loss program.
Eligibility Criteria
Patients that will be recruited for this study are those individuals that are pursuing either medical or surgical weight loss options at the Vanderbilt Centers for Medical and Surgical Weight Loss.
You may qualify if:
- English speaking
- Within the age rage of 18-70 years
- Able to give informed consent
You may not qualify if:
- Neurological disorder or previous injury (e.g. stoke, dementia, seizures, traumatic brain injury)
- History of any moderate to severe head injury (i.e. \>5 minutes of loss of consciousness)
- History of severe psychiatric illness requiring current pharmacologic therapy(e.g. schizophrenia, bipolar disorder, personality disorders)
- History of illicit drug or alcohol abuse
- Known diagnosis of learning or developmental disability
- Impaired sensory function
- Any prior suicide attempt
- Revisional bariatric surgery
- Current or former tobacco user / smoker
- Currently pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vanderbilt University Medical Centerlead
- Lumos Labs, Inc.collaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vance L Albaugh, MD, PhD
Vanderbilt University Medical Center
- STUDY DIRECTOR
Naji N Abumrad, MD
Vanderbilt University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoctoral Fellow and Resident Surgeon
Study Record Dates
First Submitted
December 12, 2016
First Posted
December 15, 2016
Study Start
July 1, 2018
Primary Completion
December 1, 2019
Study Completion
July 1, 2020
Last Updated
September 27, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share